What is Masimo?
Founded in 1989 and headquartered in Irvine, California, Masimo Corporation is a leader in developing, manufacturing, and marketing innovative noninvasive patient monitoring technologies. The company's flagship proprietary Signal Extraction Technology (SET) pulse oximetry, introduced in 1995, revolutionized patient monitoring by providing accurate measurements even under challenging conditions such as patient motion and low perfusion. Masimo's product portfolio extends to medical devices, sensors, hospital automation and connectivity solutions, and telehealth platforms, serving both hospital and home healthcare settings worldwide. The company's commitment to innovation positions it as a key player in advancing patient care through technology.
How much funding has Masimo raised?
Masimo has raised a total of $387.9M across 3 funding rounds:
Stock Offering
$233M
Grant
$5M
Debt
$150M
Stock Issuance/Offering (2007): $233M with participation from Undisclosed
Grant (2016): $5M led by Bill & Melinda Gates Foundation
Debt (2018): $150M supported by JP Morgan Chase and Bank of the West
Key Investors in Masimo
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation, established in 2000, is a major philanthropic organization focused on global health and poverty reduction, indicating a strategic interest in Masimo's life-saving medical technologies.
JP Morgan Chase
JP Morgan Chase, a leading global financial services firm, participated in Masimo's debt financing, suggesting a role in supporting the company's operational and expansionary capital needs.
Bank of the West
Bank of the West, a financial institution providing commercial and retail banking services, was involved in Masimo's debt round, likely contributing to the company's financial stability and growth initiatives.
What's next for Masimo?
The recent major strategic investment signals a new phase of growth and development for Masimo. This infusion of capital is likely to accelerate the company's research and development initiatives, potentially leading to further advancements in patient monitoring and telehealth solutions. Masimo may also leverage this financing to expand its market reach, both domestically and internationally, and to enhance its hospital automation and connectivity offerings. The company's focus on addressing critical needs in patient care suggests a strategic deployment of these funds to solidify its market leadership and drive future innovation in the medical technology landscape.
See full Masimo company page
